Duration | Topic | Speaker |
Day One: Wednesday 23 Apr 2024 | ||
Registration 08:00 - 08:30 AM | ||
08:30 - 09:00 AM | Opening Remarks | |
Theme One: Collaborations | ||
Moderators | TBA | |
09:00 - 09:20 AM | Collaborations with KMGC over the years | Dr. Andoni Urtizberea |
09:20 - 09:40 AM | Rare Mendelian disease and gene discovery | Dr. Jennifer Posey |
09:40 - 10:00 AM | Gene Matcher | Dr. Reem Elshafie |
10:00 - 10:20 AM | The Cleft & Craniofacial Registry; Clinical and Genetic Prospective | Dr. Lateefa Alkharafi |
10:20 - 10:40 AM | Collaborations with AlBahr Centre: Developing a protocol for genetic eye disease | Dr. Alaa Elshafey |
10:40 - 11:00 AM | KCC and KMGC- bridging the gap for somatic cancer genetics | Dr. Shakir Bahzad |
11:00 - 11:15 AM Panel discussion | ||
11:15 -12:00 PM Coffee & Prayer Break | ||
Theme Two: Diagnostics and preventative genetics | ||
Moderators | TBA | |
12:00 - 12:20 PM | The Debate: The Revolution of NGS and the Future of NBS | Dr. Moudhi AlMai & Mr. Mohammed Alali |
12:20 - 12:40 PM | WGS in clinical practice | Dr. Mohamed Wafik |
12:40 - 01:00 PM | Genomics in clinical practice | Dr. Ahmed Al Fares |
01:00 - 01:20 PM | Updates in NIPT | Prof. Majid Alfadhel |
01:20 - 01:30 PM Panel discussion | ||
01:30 - 02:00 PM OPENING CEREMONY | ||
02:00 - 03:00 PM Exhibition, Prayer & Lunch Break | ||
Gene-specific therapies I - Industry symposium | ||
Moderators | TBA | |
03:00 - 03:20 PM | Familial hypercholesterolemia | Dr. Ahmad Alsarraf |
03:20 - 03:40 PM | Gene therapy in epidermolysis bullosa | Dr. Arti Nanda |
03:40 - 04:00 PM | LC-FAOD | Dr. Rasha Al Safi |
04:00 - 04:10 PM Panel discussion | ||
Theme Three: Genetics of developmental disorders | ||
Moderators | TBA | |
04:10 - 04:30 PM | Developmental genetics | Dr. Nahed Alateeqi |
04:30 - 04:50 PM | 50 years autism genetic research in the world and in the Arab countries | Dr. Gianluca Esposito |
04:50 - 05:10 PM | Developmental genetics | Dr. Fowzan Alkuraya |
05:10 - 05:30 PM | Genetic counselling in autism and developmental disorders | Dr. Mona Al Saffar |
05:30 - 06:00 PM Panel discussion | ||
END OF DAY ONE |
Duration | Topic | Speaker |
Day Two: Thursday 24 Apr 2024 | ||
Theme Four: Gene-specific therapies II – Industry symposium | ||
Moderators | TBA | |
08:30 - 09:00 AM | PIK3CA-related overgrowth syndrome | Dr.Guillaume Canaud |
09:00 - 09:20 AM | Gene therapy in achondroplasia | Dr. Melita Irving |
09:20 - 09:40 AM | SMA novel therapies: Egyptian experience | Dr. Nagia Fahmi |
09:40 - 10:00 AM | ASMD | Dr. Hind Alsharhan |
10:00 - 10:20 AM | Metreleptin for the treatment of generalized lipodystrophy | Prof. Majid Alfadhel |
10:20 - 10:40 AM | Friedreich Ataxia Therapy | Dr. Dirk Deleu |
10:40 - 11:00 AM | Gene-specific therapies in cystic fibrosis | Dr. Bashar Alkhaldi |
11:00 - 11:15 AM Panel discussion | ||
11:15 - 12:00 PM Prayer & coffee Break | ||
Theme Five: Updates in clinical genetics and genomic medicine | ||
Moderators | TBA | |
12:00 - 12:20 PM | Genetics of aging | Dr. Sherif ElKhamisy |
12:20 - 12:40 PM | Novel gene discovery in Saudi | Prof. Majid Alfadhel |
12:40 - 01:00 PM | Polygenic risk score | Dr. Nilanjan Chatterjee |
01:00 - 01:20 PM | Metabolomics and dysregulated genes in Down syndrome | Dr. Tareq Mostafa |
01:20 - 01:40 PM | Clinical Research in Predictive Genomics and the return of actionable results | Mr. Donal Melanaphy |
01:40 - 01:50 PM Panel discussion | ||
01:50 - 03:00 PM Prayer & Lunch Break | ||
03:00 - 03:20 PM | Common disease genes in Kuwait and patient registry | Dr. Buthaina Bash |
03:20 - 03:40 PM | Issues in clinical research in rare diseases | Dr. Marshall Summer |
03:40 - 03:50 PM Panel discussion | ||
03:50 - 04:20 PM | Poster presentations and Prizes | |
Theme Six: Disorders of sexual development (DSD) | ||
Moderators | TBA | |
04:20 - 04:40 PM | Updates in genetic diagnosis of DSD | Dr. Doaa Ibrahim |
04:40 - 05:00 PM | DSD: an endocrinologist’s perspective | Dr. Maria Almahdi |
05:00 - 05:20 PM | Surgical intervention in DSD: updates and challenges | Dr. Abdulnasser Alsaeed |
05:20 - 05:50 PM Panel discussion | ||
05:50 - 06:00 PM | Recommendations & Ending Remarks | TBA |
END OF DAY TWO |
Follow us